
HealthEquity (HQY) Stock Forecast & Price Target
HealthEquity (HQY) Analyst Ratings
Bulls say
HealthEquity is well-positioned for long term success as it continues to expand its market share and revenue growth through strategic investments in technology and sales and marketing. The company's strong financials, including revenue of over $1 billion, an above-average combination of revenue growth and EBITDA margins, and a recurring revenue platform business model, support a multipleratingis justified. However, potential risks to the company's success include a weakening labor market, increasing competition, and changes in the regulatory environment.
Bears say
HealthEquity is facing strong competition from other healthcare-focused players such as Optum Bank and Bank of America, and its primary source of revenue relies heavily on HSAs. However, with the regulatory landscape improving for HSA eligibility expansion and inorganic growth opportunities in the fragmented market, there is potential for long-term growth. Additionally, the company has a strong leadership team, a solid balance sheet, and has shown a commitment to sustainability through its corporate sustainability committee and various employee resource groups.
This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.
HealthEquity (HQY) Analyst Forecast & Price Prediction
Start investing in HealthEquity (HQY)
Order type
Buy in
Order amount
Est. shares
0 shares